Xinran Geng

Xinran Geng

Auto-generated profile, based on publicly available information

Xinran Geng

Department of Pharmacology, Case Comprehensive Cancer Center, Case Western Reserve University, School of Medicine, Cleveland, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LZLEI ZHANG
LEI ZHANG
XGXinran Geng
Xinran Geng
FWFangfang Wang
Fangfang Wang
JTJinshan Tang
Jinshan Tang
YIYu Ichida
Yu Ichida
YZYouwei Zhang
Youwei Zhang
Human 53BP1 is primarily known as a key player in regulating DNA double strand break (DSB) repair choice; however, its involvement in other biological process is less well understood. Here, we report a previously uncharacterized function of 53BP1 at heterochromatin, where it undergoes liquid-liquid phase separation (LLPS) with the heterochromatin protein HP1α in a mutually dependent manner. Deletion of 53BP1 results in a reduction in heterochromatin centers and the de-repression of heterochromatic tandem repetitive DNA. We identify domains and residues of 53BP1 required for its LLPS, which overlap with, but are distinct from, those involved in DSB repair. Further, 53BP1 mutants deficient in DSB repair, but proficient in LLPS, rescue heterochromatin de-repression and protect cells from stress-induced DNA damage and senescence. Our study suggests that in addition to DSB repair modulation, 53BP1 contributes to the maintenance of heterochromatin integrity and genome stability through LLPS.

17 September 2021 in Science Advances
Verified
Journal Article
Open access
FPFranklin Mayca Pozo
Franklin Mayca Pozo
XGXinran Geng
Xinran Geng
ITIlaria Tamagno
Ilaria Tamagno
MJMark W. Jackson
Mark W. Jackson
EHErnest G. Heimsath
Ernest G. Heimsath
YZYouwei Zhang
Youwei Zhang
This study reveals insights into cancer development and may result in the discovery of a biomarker for cancer immunotherapy.

20 December 2024 in Science Advances
Verified
Journal Article
Open access
ZZZhemin Zhang
Zhemin Zhang
MLMeinan Lyu
Meinan Lyu
XHXu Han
Xu Han
SBSepalika Bandara
Sepalika Bandara
MCMeng Cui
Meng Cui
EYEdward W. Yu
Edward W. Yu
Malaria, a devastating parasitic infection, is the leading cause of death in many developing countries. Unfortunately, the most deadliest causative agent of malaria, Plasmodium falciparum , has developed resistance to nearly all currently available antimalarial drugs. The P. falciparum Niemann-Pick type C1–related (PfNCR1) transporter has been identified as a druggable target, but its structure and detailed molecular mechanism are not yet available. Here, we present three structures of PfNCR1 with and without the functional inhibitor MMV009108 at resolutions between 2.98 and 3.81 Å using single-particle cryo–electron microscopy (cryo-EM), suggesting that PfNCR1 binds cholesterol and forms a cholesterol transport tunnel to modulate the composition of the parasite plasma membrane. Cholesterol efflux assays show that PfNCR1 is an exporter capable of extruding cholesterol from the membrane. Additionally, the inhibition mechanism of MMV009108 appears to be due to a direct blockage of PfNCR1, preventing this transporter from shuttling cholesterol.

23 February 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
LZLEI ZHANG
LEI ZHANG
XGXinran Geng
Xinran Geng
FWFangfang Wang
Fangfang Wang
JTJinshan Tang
Jinshan Tang
YIYu Ichida
Yu Ichida
YZYouwei Zhang
Youwei Zhang